| ASPS | alveolar soft part sarcoma |
| CNA | copy number alteration |
| STS | Soft tissue sarcoma |
| ASPSCR1-TFE3 | alveolar soft part sarcoma critical region 1-transcription factor E3 |
| EORTC | European Organization for Research and Treatment of Cancer |
| FISH | fluorescence in situ hybridization |
| NSCLC | non-small cell lung cancer |
| PI3K | phosphoinositide 3-kinase |
| PD-L1 | programmed cell death protein ligand 1 |
| TIL | tumor-infiltrating lymphocyte |
| EGFR | epidermal growth factor receptor |
| TME | tumor microenvironment |
| FFPE | formalin-fixed, paraffin-embedded |
| TMA | tissue microarray |
| MILAN | Multiple Iteractive Labeling by Antibody Neodeposition |
| CTLA-4 | cytotoxic T-lymphocyte-associated protein 4 |
| PD-1 | programmed cell death protein 1 |
| MHC | major histocompatibility complex class |
| FOXP3 | forkhead box protein P3 |
| GISTIC | Genomic Identification of Significant Targets in Cancer |
| CGC | Cancer Gene Consensus |
| COSMIC | Catalogue of Somatic Mutations in Cancer databases |
| RECIST | Response Evaluation Criteria in Solid Tumors |
| PFS | progression-free |
| OS | overall survival |
| PR | partial response |
| SD | stable disease |
| PD | progressive disease |
| DAPI | 4′,6-diamidino-2-phenylindole |
| TCF | T-cell factor |
| VSC | Flemish Supercomputer Center |
| FWO | Research Foundation—Flanders |